WOMEN'S MENTAL HEALTH | PMDD AND MENSTRUAL CYCLE-RELATED MOOD SYMPTOMS
Beyond PMS: When Premenstrual Mood Symptoms May Be PMDD
Premenstrual symptoms are common, but PMDD involves a predictable pattern of mood and behavioral changes severe enough to disrupt work, relationships, or daily life. Careful symptom tracking can help distinguish PMDD from other psychiatric conditions that worsen before menstruation.
By Laura P. McLafferty, MD | Published September 13, 2026
Double Board-Certified in Psychiatry and Consultation-Liaison Psychiatry
“I’m fine the rest of the month, but I can barely function several days before my period.”
Many women notice some combination of physical discomfort, fatigue, irritability, appetite changes, or emotional sensitivity before menstruation. For some, these symptoms are uncomfortable but manageable. For others, the monthly shift is much more severe: work becomes harder, relationships feel combustible, anxiety or hopelessness intensifies, and the person may feel unlike herself for several days or longer.
Knowing that symptoms will probably improve after a period begins does not make them less disruptive while they are happening. A woman may spend part of every month trying to contain anger, panic, despair, or shame, then feel substantially better once menstruation starts. The contrast can be confusing, especially when other people see only the aftermath or dismiss the pattern as ordinary PMS.
Premenstrual dysphoric disorder, or PMDD, is a recognized psychiatric disorder. It is not a character flaw, an inability to tolerate a normal menstrual cycle, or simply “bad PMS” that someone should learn to endure. The defining questions are how severe the mood and behavioral symptoms become, how predictably they relate to the menstrual cycle, and how much they interfere with daily life.
PMS and PMDD are related, but they are not interchangeable
Premenstrual syndrome, or PMS, is a broad term for recurring emotional or physical symptoms that emerge before menstruation and improve after it begins. Symptoms can include bloating, breast tenderness, headaches, fatigue, sleep changes, food cravings, irritability, or mild mood changes. The experience varies widely, and many people can manage it without major disruption.
PMDD involves a more severe pattern of mood and behavioral symptoms. Irritability, anxiety, depressed mood, emotional volatility, difficulty concentrating, or a sense of being overwhelmed may become intense enough to impair work, relationships, decision-making, or ordinary responsibilities. Physical symptoms can occur as well, but the emotional and functional impact is usually what brings someone to psychiatric care.
The distinction is not based on whether a person is strong, productive, or able to force herself through the week. Someone can continue showing up at work or caring for a family while experiencing substantial internal distress. Functioning at great personal cost does not make the symptoms clinically unimportant.
Timing is one of the most important diagnostic clues
PMDD symptoms typically emerge during the luteal phase, in the final week or two before menstruation. They begin to improve within several days after bleeding starts and become minimal or absent during the week after the period. The exact pattern may vary somewhat from cycle to cycle, but there should be a clear relationship between symptoms and the menstrual cycle.
That timing helps distinguish PMDD from depression, anxiety, ADHD, obsessive-compulsive symptoms, bipolar disorder, or other conditions that are present throughout the month. Memory can be influenced by the most difficult days, so recalling symptoms after the fact is often not enough to establish the pattern with confidence.
Prospective daily symptom tracking across at least two menstrual cycles is therefore an important part of assessment. A diary or validated tool can record mood, irritability, anxiety, concentration, sleep, physical symptoms, menstruation, and functional impact every day, including the days when symptoms are mild or absent. Tracking is not intended to make someone monitor herself obsessively. It provides a clearer picture of whether symptoms are truly confined to the premenstrual phase, worsen from an existing baseline, or follow a different pattern altogether.
What PMDD can look like in daily life
PMDD does not look identical in every woman. Common experiences may include:
• Cyclical irritability, anger, or a lower tolerance for ordinary frustrations.
• Anxiety, panic, dread, or a sense that something is wrong even when circumstances have not changed.
• Depressed mood, hopelessness, self-critical thinking, or a sudden loss of confidence.
• Rapid emotional shifts, tearfulness, or feeling overwhelmed and unable to regain perspective.
• Difficulty concentrating, making decisions, organizing work, or completing familiar tasks.
• Relationship conflict that predictably intensifies before menstruation and improves afterward.
• Fatigue, low energy, sleep disruption, or feeling physically and emotionally depleted.
• Reduced interest in usual activities or a sense of becoming a different person for part of the month.
• Symptoms that improve substantially within several days after menstruation begins.
A predictable pattern can create its own burden. Some women begin to fear the next luteal phase, rearrange work or social plans around it, or feel ashamed about recurring conflict with people they care about. The fact that symptoms eventually lift does not erase the consequences of the days when judgment, patience, or emotional stability feel much harder to access.
PMDD is different from premenstrual exacerbation
Many psychiatric conditions become worse before menstruation. Depression, anxiety disorders, ADHD, obsessive-compulsive disorder, bipolar disorder, trauma-related symptoms, and other conditions may show premenstrual exacerbation. In that pattern, symptoms are present during the rest of the month but intensify during the luteal phase.
PMDD, by contrast, requires a distinct cyclical pattern with substantial relief outside the premenstrual window. The two patterns can also coexist: a patient may have an underlying psychiatric condition and a separate premenstrual worsening that meets criteria for PMDD.
This distinction matters because treatment planning may be different. A patient with symptoms throughout the month may need treatment aimed at the underlying condition, while someone with a sharply circumscribed premenstrual pattern may benefit from an approach targeted to that phase of the cycle. Careful tracking helps prevent both overdiagnosing PMDD and missing a meaningful menstrual-cycle component.
PMDD is not usually caused by abnormal hormone levels
It is understandable to assume that severe cyclical symptoms must mean that estrogen or progesterone levels are abnormal. Most patients with PMDD, however, do not appear to have unusually high or low reproductive hormone levels. Current models focus instead on heightened sensitivity to the normal hormonal fluctuations that occur across the menstrual cycle.
For that reason, a single hormone test generally cannot confirm or exclude PMDD. Laboratory testing may still be appropriate when a clinician is evaluating thyroid disease, anemia, medication effects, pregnancy, perimenopause, or other medical contributors, but the diagnosis depends primarily on the timing, severity, and functional impact of symptoms.
Recognizing a biological sensitivity does not mean that relationships, stress, sleep, or psychiatric history are irrelevant. Those factors can influence how symptoms are experienced and managed. Good care considers the interaction between the menstrual cycle, mental health, physical health, and the circumstances of daily life.
What a comprehensive psychiatric evaluation considers
A thoughtful evaluation is designed to clarify the symptom pattern, distinguish PMDD from other conditions, and understand what treatment options may fit the individual patient. It may include:
• The timing of mood, anxiety, cognitive, behavioral, sleep, and physical symptoms across the menstrual cycle.
• Whether symptoms become minimal after menstruation or remain present throughout the month.
• The degree of impairment at work, in relationships, at home, or in other important areas of life.
• Psychiatric history, including depression, anxiety, ADHD, OCD, bipolar disorder, trauma-related symptoms, and prior episodes of severe mood change.
• Medical and reproductive history, menstrual regularity, contraception, pregnancy plans, and possible perimenopausal changes when relevant.
• Current and previous psychiatric medications, hormonal treatments, supplements, and what happened with earlier treatment attempts.
• Sleep, stress, alcohol, caffeine, substance use, and other factors that may affect symptoms or treatment response.
• Any history of hopelessness, impulsivity, suicidal thinking, or difficulty remaining safe during the premenstrual phase.
• The involvement of an OB/GYN, primary care clinician, therapist, or other treating professionals.My background in Consultation-Liaison Psychiatry, the subspecialty focused on the relationship between mental and physical health, shapes this approach. The goal is not to assume that every premenstrual mood change is psychiatric or that every psychiatric symptom is hormonal. The goal is to understand the full pattern and develop a clear, clinically useful formulation.
Learn more about Dr. McLafferty’s training and clinical approach.
Treatment may involve more than one approach
PMDD is treatable, and there is no single plan that is right for every patient. Recommendations depend on symptom severity, the presence of symptoms outside the premenstrual phase, medical and reproductive history, contraception or pregnancy goals, prior treatment response, side effects, and personal preferences.
Selective serotonin reuptake inhibitors, or SSRIs, are among the best-supported treatments for PMDD. Depending on the patient and the clinical pattern, an SSRI may be taken continuously or during the symptomatic portion of the menstrual cycle. The response in PMDD can occur more quickly than it typically does when an SSRI is used for major depression, but dosing strategy, medication selection, and side effects still require individualized discussion and follow-up.
Hormonal treatment may also be appropriate for some patients. Certain combined oral contraceptives have evidence for improving premenstrual symptoms, particularly when contraception is also desired. Hormonal options are not interchangeable, and their medical risks, side effects, and reproductive implications should be reviewed with an OB/GYN or another clinician experienced in this area.
Psychotherapy, including cognitive behavioral approaches, can help patients respond differently to distress, reduce behaviors that amplify conflict, and prepare for predictable high-risk periods. Sleep, exercise, stress, alcohol or caffeine use, and daily routines may also influence symptom burden. These supports should not be presented as proof that PMDD is “just stress,” nor should they be treated as substitutes for clinically indicated medical or psychiatric treatment.
Follow-up matters because the first intervention may not be the final plan. Ongoing symptom tracking can show whether treatment is reducing the premenstrual spike, whether symptoms remain outside that window, and whether benefits outweigh side effects. Collaboration between psychiatry and gynecology can be particularly useful when both psychiatric and hormonal treatments are under consideration.
Birth control is not the only treatment, and medication is not always required
Patients are sometimes told that oral contraception is the only meaningful treatment for PMDD. Others assume that a psychiatric diagnosis automatically means they will need an antidepressant every day. Neither conclusion is universally correct.
The appropriate plan may involve an SSRI, a hormonal intervention, psychotherapy, behavioral supports, treatment of a coexisting psychiatric condition, or a combination. Some patients benefit from continuous medication; others may be candidates for intermittent treatment. Some need gynecologic input because contraception, medical risk, or other reproductive concerns affect the decision. A careful evaluation should explain the available options without presenting any one treatment as mandatory.
Severe premenstrual symptoms deserve prompt attention
PMDD can occasionally involve profound hopelessness, impulsivity, or suicidal thoughts. A symptom should not be dismissed as harmless simply because it appears predictably before menstruation or has improved after prior cycles.
Seek urgent help for new or markedly intensified suicidal thinking, an urge or plan to harm yourself or someone else, an inability to remain safe, severe agitation, dramatic behavioral change, confusion, hallucinations, or loss of contact with reality. In the United States, call or text 988 for immediate crisis support. Call 911 or go to the nearest emergency department when there is imminent danger or a medical or psychiatric emergency.
You do not have to lose part of everyt month
PMDD is more than “bad PMS.” It is a recurring pattern of clinically significant mood and behavioral symptoms that can affect relationships, work, confidence, and quality of life. The timing of symptoms is a central diagnostic clue, and prospective daily tracking across at least two cycles can help distinguish PMDD from psychiatric conditions that are present throughout the month or worsen premenstrually.
A predictable pattern can make symptoms understandable, but it does not make them something a woman should simply tolerate. A comprehensive evaluation can clarify what is happening, identify coexisting conditions, and support an individualized treatment plan that respects both psychiatric and reproductive health.
A cyclical pattern can explain severe symptoms. It does not make them something you should simply tolerate.
Considering an evaluation?
Dr. Laura P. McLafferty provides in-person, physician-led psychiatric care in Center City Philadelphia for adults experiencing PMDD, cyclical irritability, anxiety, depression, concentration changes, sleep disruption, or other menstrual cycle-related mental health concerns. Care is evidence-based, individualized, and coordinated with gynecologic and other treating clinicians when appropriate.
About Dr. Laura P. McLafferty
Laura P. McLafferty, MD, is double board-certified in Psychiatry and Consultation-Liaison Psychiatry. Her practice focuses on women’s mental health across the reproductive lifespan, including PMDD and menstrual cycle-related mood symptoms, pregnancy and postpartum mental health, perimenopause and menopause-related concerns, anxiety and mood disorders, and psychiatric symptoms occurring alongside complex medical conditions. She completed her psychiatry residency at the University of Pittsburgh Medical Center (UPMC) and her fellowship in Consultation-Liaison Psychiatry at Thomas Jefferson University Hospital.
Educational information only
This article is for general educational purposes and is not individualized medical advice. Reading this article or contacting the practice does not establish a physician-patient relationship. Treatment recommendations can be made only after a clinical evaluation that considers the individual patient’s symptoms, medical history, medications, reproductive circumstances, and goals. This practice does not provide emergency psychiatric services, crisis intervention, or after-hours coverage.
Selected sources
American College of Obstetricians and Gynecologists. Management of Premenstrual Disorders. ACOG Clinical Practice Guideline No. 7. Obstetrics & Gynecology. 2023;142(6):1516-1533. doi:10.1097/AOG.0000000000005426.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). American Psychiatric Association Publishing; 2022.
O’Brien PMS, Bäckström T, Brown C, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Archives of Women’s Mental Health. 2011;14(1):13-21. doi:10.1007/s00737-010-0201-3.
Bosman RC, Jung SE, Miloserdov K, Schoevers RA, aan het Rot M. Daily symptom ratings for studying premenstrual dysphoric disorder: a review. Journal of Affective Disorders. 2016;189:43-53. doi:10.1016/j.jad.2015.08.063.
Jespersen C, Lauritsen MP, Frokjaer VG, Schroll JB. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder. Cochrane Database of Systematic Reviews. 2024;8(8):CD001396. doi:10.1002/14651858.CD001396.pub4.
Ma S, Song SJ. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database of Systematic Reviews. 2023;6:CD006586. doi:10.1002/14651858.CD006586.pub5.
Yan H, Ding Y, Guo W. Suicidality in patients with premenstrual dysphoric disorder: a systematic review and meta-analysis. Journal of Affective Disorders. 2021;295:339-346. doi:10.1016/j.jad.2021.08.082.